HRCT

In the phase III INBUILD trial Nintedanib ( Ofev ) has slowed lung function decline by 57% across the overall...


The European Respiratory Journal ( ERJ ) published a manuscript entitled, FG-3019 anti-connective tissue growth factor monoclonal antibody: results of...


The extent of lung involvement visualized by high-resolution computed tomography ( HRCT ) is a predictor of decline in forced...


A pre-specified subgroup analysis from the two replicate Phase III INPULSIS trials, presented at the European Respiratory Society International Congress...


The double blind, randomised and placebo-controlled IMPULSIS trials, involving 1,066 patients across 24 countries, evaluated the effect of oral Nintedanib...


The FDA ( Food and Drug Administration ) has approved Ofev ( Nintedanib ) for the treatment of idiopathic pulmonary...


Researchers have shown that cat allergens can impair lung function in people with asthma for up to 22 hours after...